Author Topic: GH Research - private company seeking to patent a ROA  (Read 584 times)

Offline moonbeam

  • Tadpole
  • *
  • Posts: 8
  • Karma: +0/-0
    • View Profile
GH Research - private company seeking to patent a ROA
« on: February 22, 2021, 12:39:15 PM »

I was surprised to come across this private company doing a clinical study on the use of 5-MeO-DMT for treating treatment-resistant depression.  It looks like they’re seeking to patent a certain Route of Administration.  No mention of it being an adjunct to psychotherapy.

https://www.ghres.com/pipeline


GH Research Ltd. Announces Completion of Phase 1 Clinical Study with GH001 (5-Methoxy-N,N-Dimethyltryptamine) in Healthy Volunteers and Updates on Further Progress

Offline Lala155

  • Tadpole
  • *
  • Posts: 20
  • Karma: +0/-0
    • View Profile
Re: GH Research - private company seeking to patent a ROA
« Reply #1 on: March 07, 2021, 01:17:58 PM »
Super interesting!! Thanks for sharing.

Offline moonbeam

  • Tadpole
  • *
  • Posts: 8
  • Karma: +0/-0
    • View Profile
Re: GH Research - private company seeking to patent a ROA
« Reply #2 on: March 18, 2021, 12:32:07 PM »
OMG I was so naive... apparently there's a fair bit of this kind of thing going on.


https://www.vice.com/en/article/7k9359/the-race-to-patent-psychedelics-is-just-getting-started
« Last Edit: March 18, 2021, 12:33:42 PM by moonbeam »

Offline HumbleVoyager

  • Administrator
  • Transcendent Toad
  • *****
  • Posts: 775
  • Karma: +8/-0
    • View Profile
Re: GH Research - private company seeking to patent a ROA
« Reply #3 on: March 25, 2021, 06:49:02 PM »
Yes, unfortunately this sort of thing is happening all over the place.